Try searching for...
Prof. Andrew Kneebone
MBBS, FRANZCR
For patients/carers
For doctors
MBBS, FRANZCR
Locations
Clinical interests
- Gastrointestinal cancer
- Genitourinary cancer
- Prostate cancer
Languages
Fluent
- English
Biography
Clinical interests in gastrointestinal (GI), prostate, and genitourinary cancers.
Andrew is a radiation oncologist, with extensive clinical experience offering treatment for gastrointestinal (GI) and genitourinary cancers.
Andrew is a passionate and energetic clinician who’s committed to building caring and honest relationships with his patients.
His clinical experience, understanding and dedication are valuable for patients, knowing that Andrew aims to deliver high-quality, evidence-based patient care.
Andrew has been recognised by the Royal Australian and New Zealand College of Radiologists (RANZCR) with the Denise Lonergan award, for his commitment, participation, and leadership in training and education for radiation oncology.
More information
Andrew is a committed teacher for medical students and junior doctors. He lectures at the University of Sydney and has been the Director of Registrar Training for more than 20 years.
Andrew is an active researcher, with more than 140 peer reviewed publications. He is the chief investigator in several important NHMRC funded national clinical trials in prostate and pancreatic cancer.
Andrew has been an invited speaker at more than 90 conferences or meetings, and has served on numerous state and national committees on cancer management.
Andrew has been the chair of both the national Radiation Oncology Genitourinary executive (FROGG) and the Radiation Oncology Executive for the Australian Gastro-Intestinal Trials Group (AGITG). He’s also served on the National Board of the Prostate Cancer Foundation of Australia and has been made an Honorary Life member.
Andrew has developed published national guidelines for prostate cancer, bladder cancer, anal cancer, and pancreatic cancer.
This GenesisCare practitioner is a shareholder of GenesisCare Australia Holdings Pty Ltd and therefore has a pecuniary interest in GenesisCare as defined by Section 19 of the Private Health Facilities Regulation 2017 (NSW).
